Chemokine-immunoglobulin fusion polypeptides, compositions, method of making and use thereof
Abstract:
This application is directed to chemokine-immunoglobulin fusion polypeptides and chemokine-polymer conjugates. The fusion polypeptides and conjugates can be used for treating chemokine receptor-mediated disorders and modulating inflammation, inflammatory cell motility, cancer cell motility, or cancer cell survival.
Information query
Patent Agency Ranking
0/0